Zealand Pharma A/S holds the cleaner structural position, with growth as the main driver and profitability adding further support. AngloGold Ashanti does not offset that deficit through any equally strong structural edge elsewhere. In the market, AngloGold Ashanti carries the stronger setup — intact trend against Zealand Pharma A/S's broken trend. That leaves a split case: the structural lead stays with Zealand Pharma A/S, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (AU: Russell 1000, ZEAL.CO: STOXX 600).
The lead is spread across growth and profitability, rather than sitting in one isolated gap. The overall score gap is 18 points in favour of Zealand Pharma A/S.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
The match is driven mainly by investment intensity and operating margin level.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Zealand Pharma A/S looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.
On the market side, AngloGold Ashanti carries the stronger trend while Zealand Pharma A/S's trend has broken — the market setup does not confirm the structural advantage.
Growth is the clearest driver, and profitability also supports Zealand Pharma A/S's broader structural position.
Break down the AU vs ZEAL.CO comparison across all dimensions with the full interactive tool.
Explore how AU and ZEAL.CO each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.